N,N,2,3-tetramethyl-2',3',7,8-tetrahydrospiro[imidazo[1,2-a]pyrano[2,3-c]pyridine-9,10-indene]-6-carboxamide (2Z)-but-2-enedioate | 1033762-17-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡喃吡啶类
• 英文名称: N,N,2,3-tetramethyl-2',3',7,8-tetrahydrospiro[imidazo[1,2-a]pyrano[2,3-c]pyridine-9,10-indene]-6-carboxamide (2Z)-but-2-enedioate
• CAS: 1033762-17-2
• 化学式: C₄H₄O₄*C₂₃H₂₅N₃O₂
• 分子量: 491.544
• InChiKey: JWHKDNWSTLXDSM-BTJKTKAUSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.53
• 重原子数：
  36.0
• 可旋转键数：
  3.0
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  121.44
• 氢给体数：
  2.0
• 氢受体数：
  6.0

反应信息

• 作为产物：
  描述：

  N,N,2,3-tetramethyl-2',3',7,8-tetrahydrospiro[imidazo[1,2-a]pyrano[2,3-c]pyridine-9,1'-indene]-6-carboxamide 、 顺丁烯二酸 以 丙酮 为溶剂， 以73%的产率得到N,N,2,3-tetramethyl-2',3',7,8-tetrahydrospiro[imidazo[1,2-a]pyrano[2,3-c]pyridine-9,10-indene]-6-carboxamide (2Z)-but-2-enedioate
  参考文献：
  名称：

  Spiro(imidazo[1,2-a]pyrano[2,3-c]pyridine-9-indenes) as inhibitors of gastric acid secretion

  摘要：

  Asymmetric and symmetric spiro(imidazo[1,2-a]pyrano[2,3-c]pyridine-9-indenes) were prepared using a synthetic approach that comprised a cross-metathesis reaction and an acid-catalyzed cycloisomerisation as key steps. The target compounds constitute potent inhibitors of the gastric proton pump enzyme with inhibitory activity comparable to potassium-competitive acid blockers (P-CABs) belonging to the known 9-aryl-7H-8,9-dihydropyrano[2,3-c]imidazo[1,2-a]pyridine series. Spiro(imidazo[1,2-a]pyrano[2,3-c]pyridine-9,2'-indenes) represent the first example for P-CABs, in which the distance between the heterocyclic scaffold and the aryl residue has been modified, and are promising candidates for further development as anti-ulcer drugs. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2008.10.055